RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage
Open Access
Abstract
DaxibotulinumtoxinA for injection (DAXI) is a botulinum neurotoxin (BoNT) drug product comprising the 150 kDa pure BoNT/A1 as the drug substance formulated with a proprietary stabilizing excipient, RTP004. We hypothesized that RTP004 facilitates localization of BoNT/A1 to the neuronal membrane, resulting in increased BoNT internalization and cleavage of the synaptosomal-associated protein of 25 kDa (SNAP-25) within synaptic terminals. We characterized the interaction between RTP004 and BoNT/A1 using in silico and in vitro techniques. In vitro analyses revealed that negative charges on the BoNT/A1 surface were located on the light chain (LC, the catalytic domain) and the C-terminus of the heavy chain (HC, the receptor-binding domain), potentially providing sites for interaction with the positively charged RTP004 peptide. RTP004 bound to BoNT/A1, but not to human serum albumin (HSA), in both static and dynamic conditions. RTP004, not HSA, enhanced binding of BoNT to artificial membranes and RTP004 dissociated from BoNT under conditions that mimicked physiological conditions of the synaptic vesicle. RTP004 also increased binding of BoNT to the synaptosomal cell membrane and enhanced cleavage of SNAP-25 in a dose-dependent manner. These findings demonstrate that RTP004, not the excipient HSA common in other BoNT/A1 drug products, enhances binding of BoNT to the cell surface, facilitates internalization of BoNT into the cell, and increases SNAP-25 cleavage.Keywords
Funding Information
- Revance
This publication has 40 references indexed in Scilit:
- A novel peptide excipient stabilizes DaxibotulinumtoxinAInternational Journal of Pharmaceutics, 2025
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ADrugs, 2021
- Synaptosome as a tool in Alzheimer’s disease researchBrain Research, 2020
- Impact of the Endosomal Escape Activity of Cell-Penetrating Peptides on the Endocytic PathwayACS Chemical Biology, 2020
- Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing themToxicon, 2015
- An Update on the Neurologic Applications of Botulinum ToxinsCurrent Neurology and Neuroscience Reports, 2010
- Electric dipole reorientation in the interaction of botulinum neurotoxins with neuronal membranesFEBS Letters, 2009
- Two Carbohydrate Binding Sites in the HCC-domain of Tetanus Neurotoxin are Required for ToxicityJournal of Molecular Biology, 2003
- Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.Journal of Biological Chemistry, 1993